This program project is focused on the major medical complications of genital HSV infection. The first Project evaluates the interaction between HSV and HIV-1. Studies to evaluate if abrogation of HSV shedding by acyclovir reduces HIV 1 replication on mucosal surfaces and lymphoid tissue are described. HIV-1 quasispecies evolution and measurement of reservoirs of HIV-1 in cells and lymphoid tissue will be performed. Studies to determine if HSV-2 infection increases HIV-1 transmission among HIV-1 discordant couples and whether acyclovir reduces HIV-1 acquisition among HSV-2 seropositive persons are also proposed. The second Project, Maternal Morbidity and Complications of Genital Herpes is directed at determining if serological screening and counseling will reduce high-risk sexual behavior among pregnant women at risk of acquiring genital herpes. Clinical trials are proposed to develop a short course chemoprophylaxis regimen with oral and IV acyclovir analogous to Group B strep prevention.
Specific Aim 3 describes the development of a rapid assay to detect HSV DNA by PCR at labor and delivery. A cost utility analysis on strategies to improve the management of the HSV-2 seropositive pregnant women is also proposed. The third Project Lymphocyte Trafficking of Genital HSV-2 Infections. HSV specific CD8 T -cells of chronically infected persons with HSV-2 express the homing molecule CLA and this molecule is acquired during the course of infection. Studies to determine the role of CLA and other surface homing molecules on HSV specific T cells or effectors function are described. The four cores associated with the PO-1 are a Clinical Core directed at enrolling patients into the proposed trials, a Laboratory Core which performs all the HSV and HIV serological assays, HSV PCR and HIV molecular assays utilized in these studies. A Statistical Core is devoted to study-design, data management and analyses and a small Administrative Core. Collaborations with investigators in Peru, Zambia, Zimbabwe, Cameroon and Canada are proposed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI030731-13
Application #
6559351
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Savarese, Barbara M
Project Start
1991-04-01
Project End
2008-03-31
Budget Start
2003-04-15
Budget End
2004-03-31
Support Year
13
Fiscal Year
2003
Total Cost
$1,607,124
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Gilbert, Peter B; Excler, Jean-Louis; Tomaras, Georgia D et al. (2017) Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One 12:e0176428
Celum, Connie; Hong, Ting; Cent, Anne et al. (2017) Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 215:907-910
Abana, Chike O; Pilkinton, Mark A; Gaudieri, Silvana et al. (2017) Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects. J Immunol 199:3187-3201
Johnston, Christine; Magaret, Amalia; Roychoudhury, Pavitra et al. (2017) Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents. Virology 510:90-98
Agyemang, Elfriede; Le, Quynh-An; Warren, Terri et al. (2017) Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sex Transm Dis 44:763-767

Showing the most recent 10 out of 345 publications